Anktiva

nogapendekin alfa inbakicept-pmln

Approval

ApplicationBLA 761336
Approval dateApr 22, 2024
Approval year2024
SponsorAltor Bioscience, LLC, An Indirect Wholly-owned Su

FDA-approved use

To treat bladder cancer

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Anktiva: